斜视康
Published by:
Beijing Super Vision Technology Company
Description
斜视康APP免费版是一款为医生用户提供医疗辅助服务的软件，在软件中提供有
1.病例系统：医生可以通过病例系统来查找各种不同病例的手术方案设计信息，让医生可以参考以往的病例来增加对斜视手术方案设计的经验与灵感
2.查询系统：医生还可以通过查询系统来查询到更多的眼肌检查信息，让医生可以了解到更多需要的手术资料信息
3.学习园地：医生可以通过观看视频教学内容来学习更多的斜视手术方案设计，帮助医生可以成功的为病患设计出最佳的手术方案
4.扫一扫：医生可以通过患者的二维码，快速调阅患者病例信息。便于查阅
1.病例系统：医生可以通过病例系统来查找各种不同病例的手术方案设计信息，让医生可以参考以往的病例来增加对斜视手术方案设计的经验与灵感
2.查询系统：医生还可以通过查询系统来查询到更多的眼肌检查信息，让医生可以了解到更多需要的手术资料信息
3.学习园地：医生可以通过观看视频教学内容来学习更多的斜视手术方案设计，帮助医生可以成功的为病患设计出最佳的手术方案
4.扫一扫：医生可以通过患者的二维码，快速调阅患者病例信息。便于查阅
Screenshots
斜视康 FAQ
-
Is 斜视康 free?
Yes, 斜视康 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 斜视康 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 斜视康 cost?
斜视康 is free.
-
What is 斜视康 revenue?
To get estimated revenue of 斜视康 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Ukraine yet.
Ratings History
斜视康 Reviews
No Reviews in Ukraine
App doesn't have any reviews in Ukraine yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
斜视康 Installs
Last 30 days
斜视康 Revenue
Last 30 days斜视康 Revenue and Downloads
Gain valuable insights into 斜视康 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Beijing Super Vision Technology Company
- Languages
- English, Chinese
- Recent release
- 1.1.7 (1 year ago )
- Released on
- Mar 20, 2024 (1 year ago )
- Also available in
- United Arab Emirates, Nigeria, Poland, Ukraine, Austria, Hong Kong SAR China, Taiwan
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.